Aflac Incorporated (NYSE:AFL) Shares Sold by Haverford Trust Co

Haverford Trust Co lessened its position in shares of Aflac Incorporated (NYSE:AFL) by 1.4% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 7,509 shares of the financial services provider’s stock after selling 109 shares during the quarter. Haverford Trust Co’s holdings in Aflac were worth $777,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also made changes to their positions in the company. Hirtle Callaghan & Co LLC bought a new stake in shares of Aflac in the 4th quarter worth approximately $276,000. Dillon & Associates Inc. increased its position in Aflac by 6.5% in the fourth quarter. Dillon & Associates Inc. now owns 3,516 shares of the financial services provider’s stock worth $362,000 after buying an additional 216 shares during the period. Vanguard Group Inc. lifted its stake in Aflac by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 51,340,298 shares of the financial services provider’s stock valued at $5,310,640,000 after buying an additional 653,275 shares during the last quarter. Paces Ferry Wealth Advisors LLC acquired a new position in shares of Aflac during the fourth quarter valued at $13,060,000. Finally, Richwood Investment Advisors LLC grew its position in shares of Aflac by 8.1% during the fourth quarter. Richwood Investment Advisors LLC now owns 7,711 shares of the financial services provider’s stock worth $798,000 after acquiring an additional 575 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several brokerages have commented on AFL. JPMorgan Chase & Co. raised their price target on shares of Aflac from $90.00 to $94.00 and gave the company a “neutral” rating in a research note on Tuesday, January 7th. Morgan Stanley upped their target price on Aflac from $98.00 to $105.00 and gave the stock an “equal weight” rating in a research report on Friday, February 28th. Piper Sandler lowered their price target on Aflac from $122.00 to $118.00 and set an “overweight” rating on the stock in a research report on Friday, February 7th. Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an “underperform” rating for the company in a report on Wednesday, December 4th. Finally, StockNews.com raised Aflac from a “sell” rating to a “hold” rating in a report on Friday, February 14th. Two equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $103.36.

Insider Buying and Selling

In other Aflac news, EVP Audrey B. Tillman sold 24,744 shares of the company’s stock in a transaction dated Friday, December 27th. The stock was sold at an average price of $103.40, for a total value of $2,558,529.60. Following the transaction, the executive vice president now directly owns 222,618 shares of the company’s stock, valued at $23,018,701.20. This represents a 10.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Joseph L. Moskowitz sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, March 7th. The shares were sold at an average price of $107.63, for a total transaction of $107,630.00. Following the transaction, the director now directly owns 25,393 shares in the company, valued at approximately $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 55,546 shares of company stock worth $5,863,616. 0.90% of the stock is owned by company insiders.

Aflac Price Performance

AFL opened at $109.70 on Tuesday. Aflac Incorporated has a 12-month low of $79.31 and a 12-month high of $115.50. The company has a quick ratio of 0.08, a current ratio of 0.10 and a debt-to-equity ratio of 0.29. The firm has a market capitalization of $59.96 billion, a P/E ratio of 11.43, a PEG ratio of 3.24 and a beta of 0.93. The stock has a fifty day moving average of $106.09 and a 200-day moving average of $107.61.

Aflac (NYSE:AFL) last announced its quarterly earnings data on Wednesday, February 5th. The financial services provider reported $1.56 EPS for the quarter, missing analysts’ consensus estimates of $1.63 by ($0.07). Aflac had a return on equity of 16.20% and a net margin of 28.76%. Equities analysts forecast that Aflac Incorporated will post 6.88 EPS for the current fiscal year.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.